Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Sleep Initiation and Maintenance DisordersInsomnia
Interventions
DRUG

GW679769

Trial Locations (26)

19444

GSK Investigational Site, Lafayette Hill

20815

GSK Investigational Site, Chevy Chase

21702

GSK Investigational Site, Frederick

22030

GSK Investigational Site, Fairfax

27612

GSK Investigational Site, Raleigh

29621

GSK Investigational Site, Anderson

30106

GSK Investigational Site, Austell

33511

GSK Investigational Site, Brandon

34110

GSK Investigational Site, Naples

34609

GSK Investigational Site, Spring Hill

34741

GSK Investigational Site, Kissimmee

60093

GSK Investigational Site, Northfield

60634

GSK Investigational Site, Chicago

66211

GSK Investigational Site, Overland Park

68510

GSK Investigational Site, Lincoln

73112

GSK Investigational Site, Oklahoma City

78756

GSK Investigational Site, Austin

85050

GSK Investigational Site, Phoenix

85710

GSK Investigational Site, Tucson

91204

GSK Investigational Site, Glendale

91206

GSK Investigational Site, Glendale

92103

GSK Investigational Site, San Diego

92123

GSK Investigational Site, San Diego

92373

GSK Investigational Site, Redlands

92805

GSK Investigational Site, Anaheim

02886

GSK Investigational Site, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY